Related Experiment Video
Updated: Jun 23, 2026

Use of Viral Entry Assays and Molecular Docking Analysis for the Identification of Antiviral Candidates against Coxsackievirus A16
Published on: July 15, 2019
UDCA treatment against COVID-19: Do we have enough clinical evidence for drug repurposing?
Luisa Ojeda-Fernández1, Marta Baviera1, Giulia Macaluso1
1Istituto di Ricerche Farmacologiche Mario Negri IRCCS, Milan, Italy.
No abstract available in PubMed .
More Related Videos
08:41Live Imaging and Quantification of Viral Infection in K18 hACE2 Transgenic Mice Using Reporter-Expressing Recombinant SARS-CoV-2
Published on: November 5, 2021
10:25Screening Traditional Chinese Medicine Compounds for Inhibiting UCHL3 Activity Based on Molecular Docking and Deubiquitinating Enzyme Probe Technology
Published on: November 22, 2024
Related Concept Videos
Drug Discovery: Overview
Drugs for Treatment of Ulcerative Colitis in IBD
Impact of Pharmacokinetic–Pharmacodynamic Models: Regulatory Decisions
Pharmaceutical Poisoning: Treatment Strategies
Drug Therapy
Antianxiety Medications
Antiviral Nucleoside Inhibitors